Parkview Cancer Institute

Fort Wayne, Indiana 46845

2 studies enrolling now · 12 studies all time

What they study most

Advanced Solid Tumors, Chemo Fog, Chemo-brain, Chemotherapy Effect, Chemotherapy Induced Peripheral Neuropathy (CIPN), Chronic Graft Versus Host Disease, Cognitive Change, Cognitive Decline, Cognitive Dysfunction, Cognitive Impairment, Cryotherapy Effect, Heart Failure

Studies at this site

• The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study — Recruiting now
• Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy — Recruiting now
• A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib — Stopped early
• RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer — Running, not enrolling
• A Study on Impact of Canagliflozin on Health Status, Quality of Life, and Functional Status in Heart Failure — Completed
• Surveillance AFter Extremity Tumor surgerY — Running, not enrolling
• Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma — Completed
• A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) — Completed
• A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors — Stopped early
• Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms — Completed
• The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer — Stopped early
• Comparison Study in Pancreatic Fiducial Placement — Withdrawn before enrolling